Valuation : Vivos Therapeutics, Inc.

Market Cap 5.11M 4.38M 4.1M 3.76M 7.08M 488M 7.1M 48.59M 18.99M 246M 19.17M 18.76M 813M P/E 2026 *
-0.19x
P/E 2027 * -0.31x
Enterprise Value 5.11M 4.38M 4.1M 3.76M 7.08M 488M 7.1M 48.59M 18.99M 246M 19.17M 18.76M 813M EV / Sales 2026 *
0.23x
EV / Sales 2027 * 0.15x
Free-Float
72.8%
Yield 2026 *
-
Yield 2027 * -
1 day+1.26%
1 week-7.09%
Current month-36.76%
1 month-35.66%
3 months-60.78%
6 months-81.48%
Current year-87.23%
1 week 0.24
Extreme 0.24
0.3
1 month 0.24
Extreme 0.24
0.54
Current year 0.24
Extreme 0.24
2.69
1 year 0.24
Extreme 0.24
4.93
3 years 0.24
Extreme 0.24
48.79
5 years 0.24
Extreme 0.24
145.97
10 years 0.24
Extreme 0.24
360.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - 01/09/2016
Chief Executive Officer 68 01/09/2016
Director TitleAgeSince
Chairman 68 01/06/2020
Director/Board Member 87 01/06/2020
Director/Board Member 59 01/06/2020
Date Insider Type Main position Quantity % Market Cap.
7/31/26 A Free

Chief Financial Officer

400,000 2.8788%
6/30/26 A
Seneca Partners, Inc.
BuyCompany 2,749,330 19.7870%
6/30/26 A
Seneca Partners, Inc.
OtherCompany 2,749,330 19.7870%
Change 5-day change 1-year change 3-year change Capi.($)
+1.26%-7.09%-94.36%-96.01% 5.11M
-0.24%-0.46%+20.73%+27.62% 12.72B
+0.16%+0.53%+17.02%+27.98% 7B
-1.58%-2.77%+49.66%+30.67% 6.53B
+0.23%-2.82% - - 5.47B
-1.95%+12.88%-10.61%+67.52% 5.14B
+1.69%+1.58%-29.82%-21.10% 3.91B
+0.92%+2.05%+52.27%-2.53% 2.08B
-5.10%+11.40%-16.53%+136.98% 1.87B
-2.91%+2.43%+50.71%-11.59% 1.7B
Average -0.76%+2.07%+4.34%+17.73% 4.64B
Weighted average by Cap. -0.58%+1.36%+17.10%+30.33%

Financials

2026 *2027 *
Net sales 21.79M 18.7M 17.51M 16.03M 30.21M 2.08B 30.29M 207M 81.06M 1.05B 81.81M 80.04M 3.47B 34.09M 29.26M 27.39M 25.08M 47.25M 3.26B 47.39M 324M 127M 1.64B 128M 125M 5.43B
Net income -23.53M -20.2M -18.91M -17.32M -32.62M -2.25B -32.72M -224M -87.55M -1.13B -88.35M -86.45M -3.75B -14.7M -12.62M -11.82M -10.82M -20.38M -1.4B -20.44M -140M -54.7M -708M -55.21M -54.01M -2.34B
Net Debt - -
Logo Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Employees
268
Date Price Change Volume
27/08/26 $0.2593 +2.17% 1,156,465
26/08/26 $0.2538 -4.30% 15,185,135
25/08/26 $0.2652 -4.19% 1,771,807
24/08/26 $0.2768 -6.80% 249,002
21/08/26 $0.2970 +6.41% 122,785
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.2538USD
Average target price
2.117USD
Spread / Average Target
+733.99%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VVOS Stock